Diamox (acetazolamide) is a small molecule pharmaceutical. Acetazolamide was first approved as Diamox on 1982-01-01. It is used to treat altitude sickness, glaucoma, and seizures in the USA. The pharmaceutical is active against carbonic anhydrase 7. In addition, it is known to target carbonic anhydrase 1, carbonic anhydrase 12, carbonic anhydrase 13, carbonic anhydrase 4, carbonic anhydrase 14, and Carbonic anhydrase.
|Indication||altitude sickness, glaucoma, seizures|
|Drug Class||Carbonic anhydrase inhibitors|